Pharmaceutical lobby

The pharmaceutical lobby refers to the representatives of pharmaceutical drug and biomedicine companies who engage in lobbying in favour of pharmaceutical companies and their products.

Lobbying takes place at national and international levels, including institutions such as the United States Congress, the European Parliament, and the World Health Organization. Large companies such as Pfizer, Novartis, and Roche lobby directly or through trade groups like Pharmaceutical Research and Manufacturers of America (PhRMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Common methods include meetings with policymakers, public campaigns, political donations, and litigation to challenge regulations or protect patents. Critics argue this influence contributes to high drug prices and conflicts of interest, while supporters say it can support innovation and access to new medicines. The role of pharmaceutical companies in shaping international agreements and national policies remains a subject of academic and political discussion.

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.